Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting
Marshall Winget(Vanderbilt University Medical Center), Lindsay Orton(Vanderbilt University), Reena Jayani(Vanderbilt University Medical Center), James H. Jerkins(Vanderbilt University Medical Center), Adetola A. Kassim(Vanderbilt University), Elizabeth McNeer(Vanderbilt University Medical Center), Leena Choi, Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Tae Kon Kim(Vanderbilt University), Katie S. Gatwood(Vanderbilt University Medical Center), Andrew Jallouk(Vanderbilt University Medical Center), Bipin N. Savani(Vanderbilt University Medical Center), Eden Biltibo(Vanderbilt University Medical Center)
Cited by 5
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
Geriatric Assessment–Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer
|JAMA Oncology|2021|464
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|442
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2015|409